Expert Interviews

Caron A. Jacobson, MD, on Next Steps for the Phase 2 ZUMA-5 Study
August 02, 2020

Interim results from the study suggested that axicabtagene ciloleucel (axi-cel) demonstrated significant and durable clinical benefit in patients with relapsed or refractory indolent non-Hodgkin lymphoma.

Robert L. Coleman, MD, on the Role of Surgery Moving Forward in Platinum-Sensitive, Recurrent Ovarian Cancer
August 01, 2020

The US Oncology expert explained that results from 2 trials presented at the 2020 ASCO Virtual Program may change how oncologists choose to treat these patients.

Back on the Books Initiative Launched to Aid in Rescheduling Cancer Screening Appointments
July 31, 2020

The goal of the initiative is to have cancer screenings that were made in the first half of 2020 and cancelled due to COVID-19 rescheduled to ensure patients are again receiving routine screenings.